JPRN-jRCTc030200051招募中1 期
Evaluation of immune cell therapy with standard treatment for pediatric patients with malignant brain tumor.
Kondo Akihide0 个研究点目标入组 3 人开始时间: 2020年6月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 3age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •(1)Diagnosed with malignant brain tumor.
- •(2)Patients scheduled to receive surgical resection, radiotherapy and chemotherapy as standard treatment.
- •(3)70 or over of Karnofsky Performance Status (KPS) or Lansky Performance Status (LPS) score.
- •(4)Life expectancy more than 2 months after initiation of the study therapy.
- •(5)Age ranging over 3 years old and under 15 years old.
- •(6)Possible to visit outpatient department.
- •(7)Adequate function of liver, kidney, and bone marrow when eligibility is confirmed.
- •(8)Written informed consent of guardian to participate this study.
排除标准
- •(1)Apparent from the clinical manifestation of pulmonary fibrosis or interstitial pneumonia.
- •(2)A history of a serious drug allergy.
- •(3)Positive result of HIV or HTLV-1 antibody test.
- •(4)A serious cardiac disorder.
- •(5)Active autoimmune disorder.
- •(6)Cancers other than malignant brain tumor.
- •(7)An infectious disorder that is difficult to control.
研究者
相似试验
已完成
1 期
A phase I clinical study of immune cell therapy with MAGE-A4- or Survivin-specific Th1 cells for patients with refractory virulent tumorsRefractory cancer patients (MAGE-A4- or Survivin-expressing, non origin-limited) or the patients who refuse standard cancer therapyJPRN-UMIN000004828Department of General Surgery, Hokkaido University Graduated School of Medicine18
已完成
1 期
A novel cell therapy to treat patients with hepatitis C virus (HCV)infection.Hepatitis C virus infectionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemACTRN12610000067077Eric J Gowans15
尚未招募
不适用
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancerACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50
进行中（未招募）
1 期
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and AsiaMedDRA version: 20.0Level: PTClassification code: 10048240Term: Yellow fever Class: 100000004862Yellow feverCTIS2022-502047-35-00Sanofi Pasteur690
进行中（未招募）
1 期
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and AsiaEUCTR2020-005566-33-DESanofi Pasteur690